scholarly article | Q13442814 |
P356 | DOI | 10.3899/JRHEUM.120254 |
P698 | PubMed publication ID | 22751603 |
P50 | author | Arthur Kavanaugh | Q93106996 |
P2093 | author name string | Philip Mease | |
P921 | main subject | psoriatic arthritis | Q511097 |
Dactylitis | Q517782 | ||
enthesitis | Q3055079 | ||
P304 | page(s) | 90-93 | |
P577 | publication date | 2012-07-01 | |
P1433 | published in | The Journal of rheumatology. Supplement | Q27711737 |
P1476 | title | Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). | |
P478 | volume | 89 |
Q38236514 | A review of disease activity measures for psoriatic arthritis: what is the best approach? |
Q99238557 | An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis |
Q46134997 | Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. |
Q35931950 | Erythrodermic Psoriasis Treated with Golimumab: A Case Report |
Q90468513 | GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis |
Q55424021 | Golimumab: A Novel Anti-Tumor Necrosis Factor. |
Q90893942 | Pathophysiology, assessment and treatment of psoriatic dactylitis |
Q38667430 | Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis |
Q30240183 | Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. |
Q26764867 | Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies |
Q55690278 | Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies. |
Q38204241 | Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety |
Q92737085 | What does evidence-based medicine tell us about treatments for different subtypes of psoriatic arthritis? A systematic literature review on randomized controlled trials |
Q52927228 | [Psoriatic arthritis : Overview of drug therapy options and administration characteristics]. |
Q53760739 | [Psoriatic arthritis : Overview of drug therapy options and administration characteristics]. |
Search more.